We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Maelor | LSE:MLR | London | Ordinary Share | GB00B2QBY649 | ORD 70P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 100.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:8107S Maelor PLC 22 April 2008 22 April 2008 Maelor plc ( 'Maelor' or the 'Company') Consolidation and Placing The Board of Maelor plc (AIM:MLR), the specialist hospital medicines group, is pleased to announce that it has conditionally raised £10.0 million through an over subscribed placing of 13,000,000 consolidated ordinary shares of 70 pence nominal value (the 'Placing') by Noble & Company Limited, Maelor's nominated adviser and broker. Following the consolidation of the Company's existing ordinary shares on a 1 for 7 basis, commencement of dealings in relation to the 17,754,404 existing consolidated ordinary shares of 70 pence nominal value will take place today, on Tuesday 22 April 2008, at 8:00am. The ISIN of the consolidated ordinary shares is GB00B2QBY649. First Admission and the commencement of dealings in relation to the 2,288,918 First EIS/VCT Shares will also take place today, on Tuesday 22 April, at 8:00am. It is expected that Second Admission and the commencement of dealings in relation to the 546,600 Second VCT Shares will occur at 8am on 23 April 2008; that Third Admission and commencement of dealings in relation to the 8,286,482 Third VCT Shares will occur at 8am on 24 April 2007; and that Fourth Admission and the commencement of dealings in relation to the 1,878,000 Non-EIS/VCT Shares will occur at 8am on 25 April 2007. Following completion of the Fourth Admission the Company will have 30,754,404 ordinary shares of 70 pence nominal value in issue. Geoff McMillan, Non-Executive Chairman, Tim Wright, Chief Executive Officer, Nigel Goldsmith, Finance Director, Ann Hardy, Executive Director, John Gregory, Non-Executive Director and Peter Murray, Non-Executive Director have all participated in the Placing. The Board anticipates notifying the market of the completion of the acquisition of Speciality European Pharma International AG on 28 April 2008. Tim Wright, CEO of Maelor said: "We are very pleased to have completed this significant fundraising, which was over subscribed and took place in turbulent markets. We believe it shows the strength of belief in the opportunity that Maelor presents and the strategy to which the business has been delivering ever since the strengthened management team was put in place." - ENDS - Enquiries: Maelor plc Tel: +44(0) 1244 625150 Tim Wright - CEO www.maelor.plc.uk Financial Dynamics Limited Tel: +44(0) 20 7831 3113 Billy Clegg / Edward Westropp Noble & Company Limited Tel: +44(0) 20 7763 2200 Matthew Hall / Sam Reynolds This information is provided by RNS The company news service from the London Stock Exchange END MSCVFLFLVZBLBBQ
1 Year Maelor Chart |
1 Month Maelor Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions